ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000535.1|Nisin_1 # 828 # 1001 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.374	BGC0000535.1|Nisin_1 	828	1001	+	Loose	1800	21.1718	mdtC	42.86	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTACAAAAGATTTTAACTTGGATTTGGTATCTGTTTCGAAGAAAGATTCAGGTGCATCACCACGCATTACAAGTATTTCGCTATGTACACCCGGTTGTAAAACAGGAGCTCTGATGGGTTGTAACATGAAAACAGCAACTTGTCATTGTAGTATTCACGTAAGCAAATAA	MSTKDFNLDLVSVSKKDSGASPRITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	5.56	gnl|BL_ORD_ID|1212|hsp_num:0	1315			120	198	novobiocin
BGC0000535.1|Nisin_2 # 1109 # 4090 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.292	BGC0000535.1|Nisin_2 	1109	4090	+	Loose	600	26.9498	ROB-11	23.73	3007125	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGATAAAAAGTTCATTTAAAGCTCAACCGTTTTTAGTAAGAAATACAATTTTATCTCCAAACGATAAACGGAGTTTTACTGAATATACTCAAGTCATTGAGACTGTAAGTAAAAATAAAGTTTTTTTGGAACAGTTACTACTAGCTAATCCTAAACTCTATGATGTTATGCAGAAATATAATGCTGGTCTGTTAAAGAAGAAAAGGGTTAAAAAATTATTTGAATCTATTTACAAGTATTATAAGAGAAGTTATTTACGATCAACTCCATTTGGATTATTTAGTGAAACTTCAATTGGTGTTTTTTCGAAAAGTTCACAGTACAAGTTAATGGGAAAGACTACAAAGGGTATAAGATTGGATACTCAGTGGTTGATTCGCCTAGTTCATAAAATGGAAGTAGATTTCTCAAAAAAGTTATCATTTACTAGAAATAATGCAAATTATAAGTTTGGAGATCGAGTTTTTCAAGTTTATACCATAAATAGTAGTGAGCTTGAAGAAGTAAATATTAAATATACGAATGTTTATCAAATTATTTCTGAATTTTGTGAGAATGACTATCAAAAATATGAAGATATTTGTGAAACTGTAACGCTTTGCTATGGAGACGAATATAGAGAACTATCGGAACAATATCTTGGCAGTCTGATAGTTAATCATTATTTGATCTCTAATTTACAAAAAGATTTGTTGTCAGATTTTTCTTGGAACACTTTTTTGACTAAAGTTGAAGCAATAGATGAAGATAAAAAATATATAATTCCTCTGAAAAAAGTTCAAAAGTTTATTCAAGAATACTCAGAAATAGAAATTGGTGAAGGTATTGAGAAACTGAAAGAAATATATCAGGAAATGTCACAAATTCTTGAGAATGATAATTATATTCAAATTGATTTAATTAGTGATAGTGAAATAAATTTTGATGTTAAACAAAAGCAACAATTAGAACATTTAGCTGAGTTTTTAGGAAATACGACAAAATCTGTAAGAAGAACATATTTGGATGACTATAAGGATAAATTTATCGAAAAATATGGTGTAGATCAAGAAGTACAAATAACAGAATTATTTGATTCTACATTTGGCATAGGAGCTCCATATAATTATAATCATCCTCGAAATGACTTTTATGAGTCCGAACCGAGTACTCTATACTATTCAGAAGAGGAGAGAGAAAAGTACCTCAGCATGTATGTAGAAGCCGTTAAAAATCATAATGTAATTAATCTTGACGACTTAGAGTCTCATTATCAAAAAATGGACTTAGAAAAGAAAAGTGAACTTCAAGGGTTAGAATTATTTTTGAATTTGGCAAAGGAGTATGAAAAAGATATTTTTATTTTAGGGGATATCGTTGGAAATAATAATTTGGGAGGGGCATCAGGTAGATTTTCTGCACTCTCTCCGGAGTTAACAAGTTATCATAGAACGATAGTAGATTCTGTCGAAAGAGAAAATGAGAATAAAGAAATTACATCGTGTGAAATAGTATTTCTTCCAGAAAATATCAGACATGCTAACGTTATGCATACATCAATTATGAGGAGGAAAGTACTTCCATTTTTTACAAGTACAAGTCACAATGAAGTTCTGTTAACTAATATCTATATTGGAATAGACGAAAAAGAAAAATTTTATGCACGAGACATTTCAACTCAAGAGGTATTGAAATTCTACATTACAAGCATGTACAATAAAACGTTATTCAGTAATGAGCTAAGATTTCTTTACGAAATTTCATTAGATGACAAGTTTGGTAATTTACCTTGGGAACTTATTTACAGAGACTTTGATTATATTCCACGTTTAGTATTTGACGAAATAGTAATATCTCCTGCTAAATGGAAAATTTGGGGAAGGGATGTAAATAGTAAGATGACAATAAGAGAACTTATTCAAAGCAAAGAAATTCCCAAAGAGTTTTATATTGTCAATGGAGATAATAAAGTTTATTTATCACAGGAAAACCCATTGGATATGGAAATTTTAGAGTCGGCGATAAAGAAGAGCTCAAAAAGAAAAGATTTTATAGAGCTACAAGAATATTTTGAAGATGAAAATATCATAAATAAAGGAGAAAAGGGGAGAGTTGCCGATGTTGTAGTGCCTTTTATTAGAACGAGAGCATTAGGTAATGAAGGGAGAGCATTTATAAGAGAGAAAAGAGTTTCGGTTGAACGGCGTGAAAAATTGCCCTTTAACGAGTGGCTTTATCTAAAGTTGTACATTTCTATAAATCGTCAAAATGAATTTTTACTGTCGTATCTTCCAGATATTCAGAAAATAGTAGCAAACCTGGGTGGAAATCTATTCTTCCTAAGATATACTGATCCTAAACCACATATTAGATTGCGTATAAAATGTTCAGATTTATTTTTAGCTTACGGATCTATTCTTGAAATCTTAAAAAGGAGTCGGAAAAATAGGATAATGTCAACTTTTGATATTTCTATTTATGATCAAGAAGTAGAAAGATATGGTGGATTTGATACTTTAGAGTTATCCGAAGCAATATTTTGTGCCGATTCTAAAATTATTCCAAATTTGCTTACATTGATAAAAGATACTAATAATGATTGGAAAGTCGATGATGTATCAATCTTGGTGAATTATTTATATCTGAAATGCTTCTTTGAGAATGATAACAAAAAGATTCTTAATTTTTTGAATTTAGTTAGTCCTAAAAAGGTTAAAGAAAATGTCAATGAAAAGATTGAACATTATCTTAAGCTTCTGAAAGTTAATAATCTAGGTGACCAAATTTTTTATGACAAGAATTTTAAAGAATTAAAGCATGCCATAAAAAATTTATTTTTAAAAATGATAGCTCAAGATTTTGAACTTCAGAAAGTTTATTCAATTATTGACAGTATCATTCATGTCCATAATAACCGACTAATTGGTATTGAACGAGATAAAGAGAAATTAATTTATTACACACTTCAAAGGTTGTTTGTTTCGGAAGAATACATGAAATGA	MIKSSFKAQPFLVRNTILSPNDKRSFTEYTQVIETVSKNKVFLEQLLLANPKLYDVMQKYNAGLLKKKRVKKLFESIYKYYKRSYLRSTPFGLFSETSIGVFSKSSQYKLMGKTTKGIRLDTQWLIRLVHKMEVDFSKKLSFTRNNANYKFGDRVFQVYTINSSELEEVNIKYTNVYQIISEFCENDYQKYEDICETVTLCYGDEYRELSEQYLGSLIVNHYLISNLQKDLLSDFSWNTFLTKVEAIDEDKKYIIPLKKVQKFIQEYSEIEIGEGIEKLKEIYQEMSQILENDNYIQIDLISDSEINFDVKQKQQLEHLAEFLGNTTKSVRRTYLDDYKDKFIEKYGVDQEVQITELFDSTFGIGAPYNYNHPRNDFYESEPSTLYYSEEEREKYLSMYVEAVKNHNVINLDDLESHYQKMDLEKKSELQGLELFLNLAKEYEKDIFILGDIVGNNNLGGASGRFSALSPELTSYHRTIVDSVERENENKEITSCEIVFLPENIRHANVMHTSIMRRKVLPFFTSTSHNEVLLTNIYIGIDEKEKFYARDISTQEVLKFYITSMYNKTLFSNELRFLYEISLDDKFGNLPWELIYRDFDYIPRLVFDEIVISPAKWKIWGRDVNSKMTIRELIQSKEIPKEFYIVNGDNKVYLSQENPLDMEILESAIKKSSKRKDFIELQEYFEDENIINKGEKGRVADVVVPFIRTRALGNEGRAFIREKRVSVERREKLPFNEWLYLKLYISINRQNEFLLSYLPDIQKIVANLGGNLFFLRYTDPKPHIRLRIKCSDLFLAYGSILEILKRSRKNRIMSTFDISIYDQEVERYGGFDTLELSEAIFCADSKIIPNLLTLIKDTNNDWKVDDVSILVNYLYLKCFFENDNKKILNFLNLVSPKKVKENVNEKIEHYLKLLKVNNLGDQIFYDKNFKELKHAIKNLFLKMIAQDFELQKVYSIIDSIIHVHNNRLIGIERDKEKLIYYTLQRLFVSEEYMK	MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	325.57	gnl|BL_ORD_ID|4804|hsp_num:0	5795			714	891	
BGC0000535.1|Nisin_3 # 4101 # 5903 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.305	BGC0000535.1|Nisin_3 	4101	5903	+	Loose	1000	134.035	msbA	24.76	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGATGAAGTGAAAGAATTCACATCAAAACAATTTTTTAATACTTTACTTACTCTTCCAAGCACCTTGAAGTTAATTTTTCAGTTGGAAAAACGTTATGCAATTTATTTAATTGTGCTAAATGCTATCACAGCTTTTGTTCCGTTGGCTAGTCTTTTTATTTATCAAGATTTAATAAACTCTGTGCTAGGTTCAGGGAGACATCTTATCAATATTATTATCATCTATTTTATTGTTCAAGTGATAACAACAGTTCTGGGACAGCTGGAAAGTTATGTTAGTGGAAAATTTGATATGCGACTTTCTTACAGTATCAATATGCGCCTCATGAGGACTACCTCATCTCTTGAATTAAGTGATTATGAGCAGGCTGATATGTATAATATCATAGAAAAAGTTACTCAAGACAGCACTTACAAGCCTTTTCAGCTATTTAATGCTATCATTGTTGTGCTTTCATCGTTTATCTCATTGTTATCTAGTCTATTTTTTATTGGAACATGGAACATTGGGGTAGCAATTTTACTCCTTATTGTTCCAGTATTATCTTTGGTACTTTTTCTCAGAGTGGGACAATTAGAGTTTTTAATCCAGTGGCAGAGAGCAAGTTCTGAAAGAGAAACATGGTATATTGTATATTTATTGACTCATGATTTTTCATTTAAAGAAATCAAGTTAAATAATATTAGCAATTACTTCATTCATAAATTTGGAAAATTAAAGAAAGGATTTATCAACCAAGATTTAGCTATTGCTCGTAAGAAGACATATTTCAATATTTTTCTTGATTTCATTTTGAATTTGATAAATATTCTTACGATATTTGCTATGATCCTTTCGGTAAGAGCAGGAAAACTTCTTATAGGTAATTTGGTAAGTCTCATACAAGCTATTTCTAAAATCAATACTTATTCTCAAACAATGATTCAAAATATTTACATCATTTATAATACTAGTTTGTTTATGGAACAACTTTTTGAGTTTTTAAAGAGAGAAAGTGTAGTTCACAAAAAAATAGAAGATACTGAAATATGCAATCAACATATAGGAACTGTTAAAGTAATTAATTTATCATATGTTTACCCTAATTCGAATGCCTTTGCACTAAAGAATATCAATTTATCCTTTGAAAAAGGAGAATTAACTGCTATTGTAGGAAAAAATGGTTCAGGGAAAAGTACACTAGTAAAGATAATTTCAGGATTATATCAACCAACTATGGGAATAATCCAATACGACAAAATGAGAAGTAGTTTGATGCCTGAGGAGTTTTATCAGAAAAACATATCGGTGCTGTTCCAAGATTTTGTGAAGTATGAGTTAACGATAAGAGAGAATATAGGATTGAGTGATTTGTCTTCTCAATGGGAAGATGAGAAAATTATTAAAGTACTAGATAATTTAGGACTCGATTTTTTGAAAACTAATAATCAATATGTACTTGATACGCAGTTAGGAAATTGGTTTCAAGAAGGGCATCAACTTTCAGGAGGTCAGTGGCAAAAAATTGCATTAGCAAGGACATTCTTTAAGAAAGCTTCAATTTATATTTTAGATGAACCAAGTGCTGCACTCGATCCTGTAGCTGAAAAAGAAATATTTGATTATTTTGTTGCTCTTTCGGAAAATAATATTTCAATTTTCATTTCTCATAGTTTGAATGCTGCCAGAAAAGCAAATAAAATCGTGGTTATGAAAGATGGACAGGTCGAAGATGTTGGAAGTCATGATGTCCTTCTGAGAAGATGTCAATACTATCAAGAACTTTATTATTCAGAGCAATATGAGGATAATGATGAATAA	MDEVKEFTSKQFFNTLLTLPSTLKLIFQLEKRYAIYLIVLNAITAFVPLASLFIYQDLINSVLGSGRHLINIIIIYFIVQVITTVLGQLESYVSGKFDMRLSYSINMRLMRTTSSLELSDYEQADMYNIIEKVTQDSTYKPFQLFNAIIVVLSSFISLLSSLFFIGTWNIGVAILLLIVPVLSLVLFLRVGQLEFLIQWQRASSERETWYIVYLLTHDFSFKEIKLNNISNYFIHKFGKLKKGFINQDLAIARKKTYFNIFLDFILNLINILTIFAMILSVRAGKLLIGNLVSLIQAISKINTYSQTMIQNIYIIYNTSLFMEQLFEFLKRESVVHKKIEDTEICNQHIGTVKVINLSYVYPNSNAFALKNINLSFEKGELTAIVGKNGSGKSTLVKIISGLYQPTMGIIQYDKMRSSLMPEEFYQKNISVLFQDFVKYELTIRENIGLSDLSSQWEDEKIIKVLDNLGLDFLKTNNQYVLDTQLGNWFQEGHQLSGGQWQKIALARTFFKKASIYILDEPSAALDPVAEKEIFDYFVALSENNISIFISHSLNAARKANKIVVMKDGQVEDVGSHDVLLRRCQYYQELYYSEQYEDNDE	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	103.09	gnl|BL_ORD_ID|2185|hsp_num:0	2423			267	1728	metronidazole
BGC0000535.1|Nisin_5 # 7137 # 7874 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.343	BGC0000535.1|Nisin_5 	7137	7874	+	Loose	2200	26.9498	rpoB2	29.17	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAGAAGATATTTAATACTTATTGTGGCCTTAATAGGGATAACAGGTTTATCAGGGTGTTATCAAACAAGTCATAAAAAGGTGAGGTTTGACGAAGGAAGTTATACTAATTTTATTTATGATAATAAATCGTATTTCGTAACTGATAAGGAGATTCCTCAGGAGAACGTTAACAATTCCAAAGTAAAATTTTATAAGCTGTTGATTGTTGACATGAAAAGTGAGAAACTTTTATCAAGTAGCAACAAAAATAGTGTGACTTTGGTCTTAAATAATATTTATGAGGCTTCTGACAAGTCGCTATGTATGGGTATTAACGACAGATACTATAAGATACTTCCAGAAAGTGATAAGGGGGCGGTCAAAGCTTTGAGATTACAAAACTTTGATGTGACAAGCGATATTTCTGATGATAATTTTGTTATTGATAAAAATGATTCACGAAAAATTGACTATATGGGAAATATTTACAGTATATCGGACACCACCGTATCTGATGAAGAATTGGGAGAATATCAGGATGTTTTAGCTGAAGTACGTGTGTTTGATTCAGTTAGTGGCAAAAGTATCCCGAGGTCTGAATGGGGGAGAATTGATAAGGATGGTTCAAATTCCAAACAGAGTAGGACGGAATGGGATTATGGCGAAATCCATTCTATTAGAGGAAAATCTCTTACTGAAGCATTTGCCGTTGAGATAAATGATGATTTTAAGCTTGCAACGAAGGTAGGAAACTAG	MRRYLILIVALIGITGLSGCYQTSHKKVRFDEGSYTNFIYDNKSYFVTDKEIPQENVNNSKVKFYKLLIVDMKSEKLLSSSNKNSVTLVLNNIYEASDKSLCMGINDRYYKILPESDKGAVKALRLQNFDVTSDISDDNFVIDKNDSRKIDYMGNIYSISDTTVSDEELGEYQDVLAEVRVFDSVSGKSIPRSEWGRIDKDGSNSKQSRTEWDYGEIHSIRGKSLTEAFAVEINDDFKLATKVGN	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	21.08	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2178	2394	rifampin; rifaximin; rifabutin; rifapentine
BGC0000535.1|Nisin_6 # 7876 # 9924 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.339	BGC0000535.1|Nisin_6 	7876	9924	+	Loose	350	31.5722	vanI	37.29	3003723	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGAAAAAAATACTAGGTTTCCTTTTTATCGTTTGTTCGTTGGGTTTATCAGCAACTGTGCATGGGGAGACAACAAATTCACAACAGTTACTCTCAAATAATATTAATACGGAATTAATTAATCATAATTCTAATGCAATTTTATCTTCAACAGAGGGATCAACGACTGATTCGATTAATCTAGGGGCGCAGTCACCTGCAGTAAAATCGACAACAAGGACTGAATTGGATGTAACTGGTGCTGCTAAAACTTTATTACAGACATCAGCTGTTCAAAAAGAAATGAAAGTTTCGTTGCAAGAAACTCAAGTTAGTTCTGAATTCAGTAAGAGAGATAGCGTTACAAATAAAGAAGCAGTTCCAGTATCTAAGGATGAGCTACTTGAGCAAAGTGAAGTAGTCGTTTCAACATCATCGATTCAAAAAAATAAAATCCTCGATAATAAGAAGAATAGAGCTAACTTCGTTACTTCCTCTCCGCTTATTAAGGAAAAACCATCAAATTCTAAAGATGCATCTGGTGTAATTGATAATTCTGCTTCTCCTCTATCTTATCGTAAAGCTAAGGAAGTGGTATCTCTTAGACAACCTTTAAAAAATCAAAAAGTAGAGGCACAACCTCTATTGATAAGTAATTCTTCTGAAAAGAAAGCAAGTGTTTATACAAATTCACATGATTTTTGGGATTATCAGTGGGATATGAAATATGTGACAAATAATGGAGAAAGCTATGCGCTCTACCAGCCCTCAAAGAAAATTTCTGTTGGAATTATTGATTCAGGAATCATGGAAGAACATCCTGATTTGTCAAATAGTTTAGGAAATTATTTTAAAAATCTTGTTCCTAAGGGAGGGTTTGATAATGAAGAACCTGATGAAACTGGAAATCCAAGTGATATTGTCGACAAAATGGGACACGGGACGGAAGTCGCAGGTCAGATTACAGCAAATGGTAATATTTTAGGAGTAGCACCAGGGATTACTGTAAATATATACAGAGTATTTGGTGAAAATCTTTCGAAATCGGAATGGGTAGCTAGAGCAATAAGAAGAGCTGCGGATGATGGGAACAAGGTCATCAATATAAGTGCTGGACAGTATCTTATGATTTCAGGATCGTATGATGATGGAACAAATGATTATCAAGAGTATCTTAATTATAAGTCAGCAATAAATTATGCAACAGCAAAAGGAAGTATTGTTGTCGCAGCTCTTGGTAATGATAGTTTAAACATACAAGATAACCAAACAATGATAAACTTTCTTAAGCGTTTCAGAAGTATAAAGGTTCCTGGAAAAGTTGTAGATGCACCGAGTGTATTTGAGGATGTAATAGCCGTAGGTGGAATAGATGGTTATGGTAATATTTCTGATTTTAGTAATATTGGAGCGGATGCAATTTATGCTCCTGCTGGCACAACGGCCAATTTTAAAAAATATGGGCAAGATAAATTTGTCAGTCAGGGTTATTATTTGAAAGATTGGCTTTTTACAACTACTAATACTGGCTGGTACCAATATGTTTATGGCAACTCATTTGCTACTCCTAAAGTATCTGGGGCACTGGCATTAGTAGTTGATAAATATGGAATAAAGAATCCTAACCAACTAAAAAGGTTTCTTCTAATGAATTCTCCAGAAGTTAATGGGAATAGAGTATTGAATATTGTTGATTTATTGAATGGGAAAAATAAAGCTTTTAGCTTAGATACAGATAAAGGTCAGGATGATGCTATTAACCATAAATCGATGGAGAATCTTAAAGAGTCTAGGGATACAATGAAACAGGAACAAGATAAAGAAATTCAAAGAAATACAAATAACAATTTTTCTATCAAAAATGATTTTCATAACATTTCAAAAGAAGTAATTTCAGTTGATTATAATATTAATCAAAAAATGGCTAATAATCGAAATTCGAGAGGTGCTGTTTCTGTACGAAGTCAAGAAATTTTACCTGTTACTGGAGATGGAGAAGATTTTTTACCGGCTTTAGGTATAGTGTGTATCTCAATCCTTGGTATATTGAAAAGAAAGACTAAAAATTGA	MKKILGFLFIVCSLGLSATVHGETTNSQQLLSNNINTELINHNSNAILSSTEGSTTDSINLGAQSPAVKSTTRTELDVTGAAKTLLQTSAVQKEMKVSLQETQVSSEFSKRDSVTNKEAVPVSKDELLEQSEVVVSTSSIQKNKILDNKKNRANFVTSSPLIKEKPSNSKDASGVIDNSASPLSYRKAKEVVSLRQPLKNQKVEAQPLLISNSSEKKASVYTNSHDFWDYQWDMKYVTNNGESYALYQPSKKISVGIIDSGIMEEHPDLSNSLGNYFKNLVPKGGFDNEEPDETGNPSDIVDKMGHGTEVAGQITANGNILGVAPGITVNIYRVFGENLSKSEWVARAIRRAADDGNKVINISAGQYLMISGSYDDGTNDYQEYLNYKSAINYATAKGSIVVAALGNDSLNIQDNQTMINFLKRFRSIKVPGKVVDAPSVFEDVIAVGGIDGYGNISDFSNIGADAIYAPAGTTANFKKYGQDKFVSQGYYLKDWLFTTTNTGWYQYVYGNSFATPKVSGALALVVDKYGIKNPNQLKRFLLMNSPEVNGNRVLNIVDLLNGKNKAFSLDTDKGQDDAINHKSMENLKESRDTMKQEQDKEIQRNTNNNFSIKNDFHNISKEVISVDYNINQKMANNRNSRGAVSVRSQEILPVTGDGEDFLPALGIVCISILGILKRKTKN	MTKLKIAIIFGGCSEEHPVSVKSAGEVAKNLDPEKYEPFYIGITKDGVWQLCHYPEVNWEKGSCRPAILSPDRSVQGLLVLEQGQYQRIPLDLVFPVLHGKFGEDGAMQGLLELSGIPYVGCDIPSSALCMDKSLAYIVAGKAGIATPKFRTVTVKETIDAERLTYPVYVKPARSGSSFGVTKVCRQEELLNAVEIASQYDSKVLIEETVIGTEIGCAIFGNDLDLIAGEVDQIRLSHGFFRIHQENEPEKGSENSTLIVPAGISAEARSRVQETAKAIYRALGCRGLARVDMFLKEDGTVILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLALKGKTGTN	195.98	gnl|BL_ORD_ID|2043|hsp_num:0	2241			6	171	vancomycin; teicoplanin
BGC0000535.1|Nisin_7 # 9990 # 10679 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.339	BGC0000535.1|Nisin_7 	9990	10679	+	Loose	400	142.51	vanR gene in vanM cluster	36.56	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGGTGTATAAAATTTTAATAGTTGATGATGATCAGGAAATTTTAAAATTAATGAAGACAGCATTAGAAATGAGAAACTATGAAGTTGCGATGCATCAAAACATTTCACTTCCCTTGGATATTACTGATTTTCAGGGATTTGATTTGATTTTGTTAGATATCATGATGTCAAATATTGAAGGGACAGAAATTTGTAAAAGGATTCGCAGAGAAATATCAACTCCAATTATCTTTGTTAGTGCGAAAGATACAGAAGAGGATATTATAAACGGCTTAGGTATTGGTGGGGATGACTATATTACTAAGCCTTTTAGCCTTAAACAGTTGGTTGCAAAAGTGGAAGCAAATATAAAGCGAGAGGAACGCAATAAACATGCAGTTCATGTTTTTTCAGAGATTCGTAGAGATTTAGGACCAATTACATTTTATTTAGAAGAAAGGCGAGTCTGTGTCAATGGTCAAACAATTCCACTGACTTGTCGTGAATACGATATTCTTGAATTACTATCACAACGAACTTCTAAAGTTTATACGAGAGAGGATATTTATGATGACGTATATGATGAATATTCTAATGCACTTTTTCGGTCAATCTCGGAATATATTTATCAGATTAGGAGTAAGTTTGCACCATACGATATTAATCCGATAAAAACGGTTCGGGGACTTGGGTATCAGTGGCATGGGTAA	MVYKILIVDDDQEILKLMKTALEMRNYEVAMHQNISLPLDITDFQGFDLILLDIMMSNIEGTEICKRIRREISTPIIFVSAKDTEEDIINGLGIGGDDYITKPFSLKQLVAKVEANIKREERNKHAVHVFSEIRRDLGPITFYLEERRVCVNGQTIPLTCREYDILELLSQRTSKVYTREDIYDDVYDEYSNALFRSISEYIYQIRSKFAPYDINPIKTVRGLGYQWHG	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	98.71	gnl|BL_ORD_ID|4735|hsp_num:0	752			15	696	vancomycin; teicoplanin
BGC0000535.1|Nisin_8 # 10672 # 12015 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.315	BGC0000535.1|Nisin_8 	10672	12015	+	Loose	800	58.5362	ParS	22.54	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGGGTAAAAAATATTCAATGCGTCGACGGATATGGCAAGCTGTCATTGAAATTATCATAGGTACTTGTCTACTTATCCTGTTGTTACTGGGCTTGACTTTCTTTCTACGACAAATTGGACAAATCAGTGGTTCAGAAACTATTCGTTTATCTTTAGATTCAGATAATTTAACTATTTCTGATATCGAACGTGATATGAAACACTACCCATATGATTATATTATTTTTGACAATGATACAAGTAAAATTTTGGGAGGACATTATGTCAAGTCGGATGTACCTAGTTTTGTAGCTTCAAAACAGTCTTCACATAATATTACAGAAGGAGAAATTACTTATACTTATTCAAGCAATAAGCATTTTTCAGTTGTTTTAAGACAAAACAGTATGCCTGAATTTACAAATCATACGCTTCGTTCAATTTCTTATAATCAATTTACTTACCTTTTCTTTTTTCTTGGTGAAATAATACTCATTATTTTTTCTGTCTATCATCTCATTAGAGAATTTTCTAAGAATTTTCAAGCCGTTCAAAAGATTGCATTGAAGATGGGGGAAATAACTACTTTTCCTGAACAAGAGGAATCAAAAATTATTGAATTTGATCAGGTTCTGAATAACTTATATTCGAAAAGTAAGGAGTTAGCTTTCCTTATTGAAGCGGAGCGTCATGAAAAACATGATTTATCCTTCCAGGTTGCTGCACTTTCACATGATGTTAAGACACCTTTAACAGTATTAAAAGGAAATATTGAACTGCTAGAGATGACTGAAGTAAATGAACAACAAGCTGATTTTATTGAGTCAATGAAAAATAGTTTGACTGTTTTTGACAAGTATTTTAACACAATGATTAGTTATACAAAACTTTTGAATGATGAAAATGATTACAAAGCGACAATCTCCCTGGAGGATTTTTTGATAGATTTATCAGTTGAGTTGGAAGAGTTGTCAACAACTTATCAAGTGGATTATCAGCTAGTTAAAAAAACAGATTTAACCACTTTTTACGGAAATACATTAGCTTTAAGTCGAGCACTTATCAATATCTTTGTTAATGCCTGTCAGTATGCTAAAGAGGGTGAAAAAATAGTCAGTTTGAGTATTTATGATGATGAAAAATATCTCTATTTTGAAATCTGGAATAATGGTCATCCTTTTTCTGAACAAGCAAAAAAAAATGCTGGAAAACTATTTTTCACAGAAGATACTGGACGTAGTGGGAAACACTATGGGATTGGACTATCTTTTGCTCAAGGTGTAGCTTTAAAACATCAAGGAAACTTAATTCTCAGTAATCCTCAAAAAGGTGGGGCAGAAGTTATCCTAAAAATAAAAAAGTAA	MGKKYSMRRRIWQAVIEIIIGTCLLILLLLGLTFFLRQIGQISGSETIRLSLDSDNLTISDIERDMKHYPYDYIIFDNDTSKILGGHYVKSDVPSFVASKQSSHNITEGEITYTYSSNKHFSVVLRQNSMPEFTNHTLRSISYNQFTYLFFFLGEIILIIFSVYHLIREFSKNFQAVQKIALKMGEITTFPEQEESKIIEFDQVLNNLYSKSKELAFLIEAERHEKHDLSFQVAALSHDVKTPLTVLKGNIELLEMTEVNEQQADFIESMKNSLTVFDKYFNTMISYTKLLNDENDYKATISLEDFLIDLSVELEELSTTYQVDYQLVKKTDLTTFYGNTLALSRALINIFVNACQYAKEGEKIVSLSIYDDEKYLYFEIWNNGHPFSEQAKKNAGKLFFTEDTGRSGKHYGIGLSFAQGVALKHQGNLILSNPQKGGAEVILKIKK	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	104.44	gnl|BL_ORD_ID|2790|hsp_num:0	3805			642	1257	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000535.1|Nisin_9 # 12114 # 12791 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.323	BGC0000535.1|Nisin_9 	12114	12791	+	Loose	570	167.548	bcrA	43.96	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCAGGTAAAAATTCAAAATCTTTCTAAAACATATAAAGAAAAGCAGGTGCTACAAGATATCAGTTTTGATATTAAATCTGGAACAGTCTGTGGTTTATTAGGAGTTAACGGTGCAGGAAAATCAACTTTGATGAAAATTTTGTTTGGTTTAATTTCTGCAGATACTGGAAAAATTTTTTTTGATGGACAAGAAAAGACAAATAATCAACTTGGAGCCTTAATCGAGGCTCCAGCAATATATATGAATTTATCTGCTTTCGATAATCTTAAAACTAAGGCTTTGCTTTTTGGAATTTCAGATAAGAGAATTCATGAAACTCTAGAAGTGATTGGTTTGGCAGAAACAGGAAAGAAAAGAGCAGGAAAATTCTCTTTAGGGATGAAACAACGTTTGGGAATTGGTATGGCTATTCTTACAGAACCTCAATTTTTAATTCTTGATGAACCTACTAATGGTTTGGATCCTGATGGTATTGCGGAGTTGTTAAACTTAATCTTAAAACTTAAAGCTAAAGGTGTGACAATCTTGATTTCTAGTCATCAGTTGCACGAAATAAGTAAAGTAGCTAGTCAAATTATTATTTTGAACAAAGGTAAGATTCGTTATAATCATGCGAACAATAAAGAAGACGACATTGAACAGTTATTCTTTAAGATTGTGCATGGAGGAATGTGA	MQVKIQNLSKTYKEKQVLQDISFDIKSGTVCGLLGVNGAGKSTLMKILFGLISADTGKIFFDGQEKTNNQLGALIEAPAIYMNLSAFDNLKTKALLFGISDKRIHETLEVIGLAETGKKRAGKFSLGMKQRLGIGMAILTEPQFLILDEPTNGLDPDGIAELLNLILKLKAKGVTILISSHQLHEISKVASQIIILNKGKIRYNHANNKEDDIEQLFFKIVHGGM	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	73.53	gnl|BL_ORD_ID|315|hsp_num:0	345			12	633	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000535.1|Nisin_10 # 12793 # 13521 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316	BGC0000535.1|Nisin_10 	12793	13521	+	Loose	900	25.0238	PmpM	28.57	3004077	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGAAAAGAATAATAGCATCAGAAGCAATAAAATTAAAAAAATCAGGAACTCTTAGATTGGTATTAATTATCCCTTTTGTGACTCTATTTATAGCATTTCTTATGGGTGGAATACAGATTTTTAGTGTTTTTTCAATTTATTGGTGGGAAACTGGTTTTTTATTCCTTTTGATGAGTTTGCTTTTTCTTTATGATATAAAATCAGAGGAGCAAGCTGGAAATTTTCAAAATGTGAAATGGAAAAAGCTGAGTTGGAAAATTCATTTGGCCAAAATGTTGTTGATTTGGCTAAGAGGTATACTAGCGAGCATAGTCTTGATTATTTTGCTTTATTTGGTTGCTTTTGTGTTTCAAGGTATTGTAGTGGTGGATTTTATGAAAGTAAGTGTGGCATTGATTGCTATATTACTAGCAGCTTCTTGGAATTTACCCTTTATATACTTGATTTTCAAGTGGATTAATACTTACGTATTGTTAGCTGCGAATACCTTGATTTGTTTAATTGTTGCCCCTTTTGTTGCACAAACTCCAGTATGGTTCTTGCTACCATACACTTATCACTATAAAGTTACAGAAAGTTTGTTAAATATCAAACCATCAGGAGATTTGTTAACAGGGAAGATAAATTTCAGTATTTGGGAAGTTTTATTACCATTTGGACTTTCCATAGTTGTAACGATAGGAGTTTCGTATTTACTTAAAGGAGTGATAGAACATGATAAGAAGTGA	MKRIIASEAIKLKKSGTLRLVLIIPFVTLFIAFLMGGIQIFSVFSIYWWETGFLFLLMSLLFLYDIKSEEQAGNFQNVKWKKLSWKIHLAKMLLIWLRGILASIVLIILLYLVAFVFQGIVVVDFMKVSVALIAILLAASWNLPFIYLIFKWINTYVLLAANTLICLIVAPFVAQTPVWFLLPYTYHYKVTESLLNIKPSGDLLTGKINFSIWEVLLPFGLSIVVTIGVSYLLKGVIEHDKK	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	50.73	gnl|BL_ORD_ID|2378|hsp_num:0	2734			861	966	neomycin; benzalkonium chloride; chlorhexidine
BGC0000535.1|Nisin_11 # 13508 # 14152 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.326	BGC0000535.1|Nisin_11 	13508	14152	+	Loose	500	25.0238	AAC(3)-IIIb	47.62	3002537	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGATAAGAAGTGAATGTCTCAAATTAAAAAATAGCTTAGGGTTTTATTTAGTTTTTCTCTTTACTTTATTAGAGCTTTTAACGGTTCCTATTTATTTAGCTTTTGGAAGAAGTCATGTTTCAATGACTGATTTATCGCTCATGATTTTTTTGTTTTTTCCGTTACTGGTTACAATTTTGTCTATTCTAATCTTTGAACAGGAGAGTCTGGCCAATCGTTTCCAAGAAATAAATGTAAATAAAAAAAGTAGCAGAATTTGGTTATCAAAGCTAATAGTAGTGGATTTCCTTTTGTTCTTTCCATCAGCAATGATCTGGATAATTACGGGAGTTTCACAGGCAGTAGGGCAACAAGGAATGATGATCGCAACAGCTAGCTGGTTGATGGCAATTTTTCTTAATCATTTTCATCTTTTATTGACCTTTATAATCAATCGAGGAGGGAGCATGATTATCGCGATTATTGAAATATTACTCATTATTTTTGCCAGTAATAAAGTTTTATTAGCAGCTTATTGGTGTCCCATTGCTTTACCTGTTAATTTTATGATAACTGGGCGGTGTGCTTATCTGATAGCTGCCGTAGGGTGGATTGTTTTATCCACAATAATTCTTGTAGCATTATCTAAAAAAAAGATTAGATAA	MIRSECLKLKNSLGFYLVFLFTLLELLTVPIYLAFGRSHVSMTDLSLMIFLFFPLLVTILSILIFEQESLANRFQEINVNKKSSRIWLSKLIVVDFLLFFPSAMIWIITGVSQAVGQQGMMIATASWLMAIFLNHFHLLLTFIINRGGSMIIAIIEILLIIFASNKVLLAAYWCPIALPVNFMITGRCAYLIAAVGWIVLSTIILVALSKKKIR	MTPASFVTRASLAADLASLGLAPGDAVMVHAAVSKVGRLLDGPDTIISALSDAVGPEGTVLAYADWEARYEELADEHGRVPVQWRDHIPPFDPQRSRAIRDNGVLPEFLRTTPGALRSGNPGASVVALGAKAEWFTADHPLDYGYGEGSPLAKLVAAGGRVLMLGAPLDTLTLLHHAEHLADIPGKRIKRIEVPFATPTGTQWRMIEEFDTGDPIVAGLAEDYFAGIVTEFLASGQGRQGLIGAAPSVLVDAAAITAFGVTWLEKRFGTPSP	78.68	gnl|BL_ORD_ID|370|hsp_num:0	410			135	198	neomycin; dibekacin; sisomicin; kanamycin A; tobramycin; paromomycin; lividomycin; 5-episisomicin; gentamicin
BGC0000535.1|Nisin_12 # 14666 # 15016 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.345	BGC0000535.1|Nisin_12 	14666	15016	-	Loose	850	24.2534	opmE	33.33	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTAGTGCAAAGGACTTTGAATAAGGCAATGGAATCACAAAATTATCCAGAAGCTGTGATGCTTCATTCTGACCAAGGAAGTCAGTATACGAGTCATGAGTATGAAGAGACAATAAAAAACTCTGGAATGACTCACTCCTTCAGTCGTAAGGGCTATCCTTATCATAATGCCAGTCTTGAATCTTGGCATGGACATTTAAAAAGAGAGTGGGTCTATCAATTTAAATATAAGAACTTTGAAGAAGCCTATCAGAGTATTTTCTGGTATATTGAAGCCTTTTATAATTCAAAACGAATCCATCAAAGTTTAGGGTATCTTACGCCTAATCAATTTGAAAAAGAAATCACTTAA	LVQRTLNKAMESQNYPEAVMLHSDQGSQYTSHEYEETIKNSGMTHSFSRKGYPYHNASLESWHGHLKREWVYQFKYKNFEEAYQSIFWYIEAFYNSKRIHQSLGYLTPNQFEKEIT	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	23.63	gnl|BL_ORD_ID|2019|hsp_num:0	2213			552	651	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
